BMJ  2005;331 (1 October), doi:10.1136/bmj.331.7519.0-a

What works for malaria

Guidelines for treating children with uncomplicated malaria changed in Zambia in 2002 in line with the best available evidence, but the change has not yet translated into adequate use at the point of care. A cross sectional study by Zurovac and colleagues (p 734) shows how artemether-lumefantrine, which should be the first choice of treatment for children weighing 10 kg or more, is not being prescribed even when available.

Credit: GIACOMO PIROZZI/PANOS

In a cluster randomised trial, Chandramohan and colleagues (p 727) showed that sulfadoxine-pyrimethamine can prevent malaria and anaemia in infants up to 15 months old. These children may also have a higher risk of high parasite density malaria after treatment is stopped, however.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana
Daniel Chandramohan, Seth Owusu-Agyei, Ilona Carneiro, Timothy Awine, Kwame Amponsa-Achiano, Nathan Mensah, Shabbar Jaffar, Rita Baiden, Abraham Hodgson, Fred Binka, and Brian Greenwood
BMJ 2005 331: 727-733. [Abstract] [Full Text] [PDF]

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study
Dejan Zurovac, Mickey Ndhlovu, Alexander K Rowe, Davidson H Hamer, Donald M Thea, and Robert W Snow
BMJ 2005 331: 734. [Abstract] [Full Text] [PDF]




Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview